Tango Therapeutics to Present at Three Upcoming Investment Bank Conferences
Tango Therapeutics (NASDAQ: TNGX), a clinical-stage biotechnology company focused on precision cancer medicines, has announced its participation in three major investment bank conferences in early 2025.
The company will participate in:
- The B Riley Precision Oncology & Radiopharma Conference in New York, featuring a panel discussion on 'Pushing Tumors Over the Edge with Synthetic Lethality' on February 28 at 9:00 AM ET
- The Leerink Global Healthcare Conference in Miami, hosting a fireside chat on March 12 at 2:20 PM ET
- The Barclays 27th Annual Global Healthcare Conference in Miami on March 13, available for one-on-one meetings
Webcasts will be available on the company's website under the 'Events & Presentations' tab, with replays archived for 90 days post-presentation.
Tango Therapeutics (NASDAQ: TNGX), un'azienda biotecnologica in fase clinica focalizzata su farmaci oncologici di precisione, ha annunciato la sua partecipazione a tre importanti conferenze di banche d'investimento all'inizio del 2025.
L'azienda parteciperà a:
- La B Riley Precision Oncology & Radiopharma Conference a New York, con una discussione di panel su 'Spingere i tumori oltre il limite con la letalità sintetica' il 28 febbraio alle 9:00 AM ET
- La Leerink Global Healthcare Conference a Miami, con un colloquio informale il 12 marzo alle 2:20 PM ET
- La Barclays 27th Annual Global Healthcare Conference a Miami il 13 marzo, disponibile per incontri individuali
Le trasmissioni in diretta saranno disponibili sul sito web dell'azienda nella sezione 'Eventi e Presentazioni', con le registrazioni archiviate per 90 giorni dopo la presentazione.
Tango Therapeutics (NASDAQ: TNGX), una compañía biotecnológica en etapa clínica centrada en medicamentos oncológicos de precisión, ha anunciado su participación en tres importantes conferencias de bancos de inversión a principios de 2025.
La compañía participará en:
- La B Riley Precision Oncology & Radiopharma Conference en Nueva York, que contará con una discusión en panel sobre 'Empujando los tumores al límite con letalidad sintética' el 28 de febrero a las 9:00 AM ET
- La Leerink Global Healthcare Conference en Miami, que albergará una charla informal el 12 de marzo a las 2:20 PM ET
- La Barclays 27th Annual Global Healthcare Conference en Miami el 13 de marzo, disponible para reuniones uno a uno
Las transmisiones en vivo estarán disponibles en el sitio web de la compañía en la pestaña 'Eventos y Presentaciones', con repeticiones archivadas durante 90 días después de la presentación.
탱고 테라퓨틱스 (NASDAQ: TNGX), 정밀 암 의약품에 중점을 둔 임상 단계의 생명공학 회사가 2025년 초에 세 가지 주요 투자은행 회의에 참여한다고 발표했습니다.
회사는 다음 회의에 참여할 예정입니다:
- B 라이리 정밀 온콜로지 및 방사선 약품 회의가 뉴욕에서 열리며, 2월 28일 오전 9시(ET)에 '합성 치사성으로 종양을 극복하기'에 대한 패널 토론이 진행됩니다.
- 리링크 글로벌 헬스케어 회의가 마이애미에서 열리며, 3월 12일 오후 2시 20분(ET)에 화재 측면 대화가 진행됩니다.
- 바클레이스 제27회 연례 글로벌 헬스케어 회의가 마이애미에서 3월 13일에 열리며, 개별 미팅이 가능합니다.
웹캐스트는 회사 웹사이트의 '이벤트 및 발표' 탭에서 제공되며, 발표 후 90일 동안 재생이 보관됩니다.
Tango Therapeutics (NASDAQ: TNGX), une entreprise biotechnologique en phase clinique axée sur les médicaments anticancéreux de précision, a annoncé sa participation à trois grandes conférences bancaires d'investissement au début de 2025.
L'entreprise participera à :
- La B Riley Precision Oncology & Radiopharma Conference à New York, avec une discussion en panel sur 'Pousser les tumeurs à la limite avec la létalité synthétique' le 28 février à 9h00 ET
- La Leerink Global Healthcare Conference à Miami, qui accueillera un entretien informel le 12 mars à 14h20 ET
- La Barclays 27th Annual Global Healthcare Conference à Miami le 13 mars, disponible pour des réunions individuelles
Les webcasts seront disponibles sur le site web de l'entreprise sous l'onglet 'Événements & Présentations', avec des rediffusions archivées pendant 90 jours après la présentation.
Tango Therapeutics (NASDAQ: TNGX), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf präzise Krebsmedikamente konzentriert, hat seine Teilnahme an drei wichtigen Investorenkonferenzen Anfang 2025 angekündigt.
Das Unternehmen wird an folgenden Veranstaltungen teilnehmen:
- Der B Riley Precision Oncology & Radiopharma Conference in New York, die am 28. Februar um 9:00 Uhr ET eine Podiumsdiskussion mit dem Thema 'Tumoren mit synthetischer Letalität über die Grenze drücken' bietet
- Der Leerink Global Healthcare Conference in Miami, die am 12. März um 14:20 Uhr ET ein informelles Gespräch veranstaltet
- Der Barclays 27th Annual Global Healthcare Conference in Miami am 13. März, die für Einzelgespräche zur Verfügung steht
Webcasts werden auf der Unternehmenswebsite unter dem Reiter 'Veranstaltungen & Präsentationen' verfügbar sein, mit Wiederholungen, die 90 Tage nach der Präsentation archiviert werden.
- None.
- None.
BOSTON, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Feb. 20, 2025-- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that Tango Therapeutics management is scheduled to participate in three upcoming investment bank conferences. The B Riley Precision Oncology & Radiopharma Conference will be held in New York, NY in late February. The Leerink Global Healthcare Conference and Barclays 27th Annual Global Healthcare Conference will be held in Miami, FL in March.
B Riley Precision Oncology & Radiopharma Conference
- Panel participation on Friday, February 28 at 9:00-10:00 AM ET
- Panel title “Pushing Tumors Over the Edge with Synthetic Lethality”
Leerink Global Healthcare Conference
- Fireside chat on Wednesday, March 12 at 2:20-2:50 PM ET
- Webcast link HERE
Barclays 27th Annual Global Healthcare Conference
- Available for 1x1 meetings on Thursday, March 13
The live webcast for each event will be available under the "Events & Presentations" tab on the “Investors” page of the Company's website on the day of the event. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.
If you are interested in arranging a 1x1 meeting with management, please contact your conference representative.
About Tango Therapeutics
Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. For more information, please visit www.tangotx.com.
Investor Contact:
Daniella Beckman
Chief Financial Officer, Tango Therapeutics
IR@tangotx.com
Media Contact:
Daniella Beckman
Chief Financial Officer, Tango Therapeutics
media@tangotx.com
Source: Tango Therapeutics, Inc.
FAQ
What conferences will Tango Therapeutics (TNGX) attend in early 2025?
When is Tango Therapeutics' (TNGX) panel discussion at the B Riley Conference?
What is the schedule for TNGX's presentation at the Leerink Global Healthcare Conference?
How long will TNGX's conference webcasts be available for viewing?
Where can investors access TNGX's conference presentations?
